These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16407187)

  • 41. NPC1L1: evolution from pharmacological target to physiological sterol transporter.
    Huff MW; Pollex RL; Hegele RA
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2433-8. PubMed ID: 16973966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The structure and function of Niemann-Pick C1-like 1 protein.
    Yu L
    Curr Opin Lipidol; 2008 Jun; 19(3):263-9. PubMed ID: 18460917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe.
    Schweitzer M; Makhoul S; Paliouras M; Beitel LK; Gottlieb B; Trifiro M; Chowdhury SF; Zaman NM; Wang E; Davis H; Chalifour LE
    Atherosclerosis; 2016 Mar; 246():78-86. PubMed ID: 26761771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe.
    Wang J; Williams CM; Hegele RA
    Clin Genet; 2005 Feb; 67(2):175-7. PubMed ID: 15679830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
    Davis HR; Altmann SW
    Biochim Biophys Acta; 2009 Jul; 1791(7):679-83. PubMed ID: 19272334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver.
    Kurano M; Hara M; Tsuneyama K; Okamoto K; Iso-O N; Matsushima T; Koike K; Tsukamoto K
    J Lipid Res; 2012 Nov; 53(11):2275-85. PubMed ID: 22891292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
    Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
    Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Progress of Niemann-Pick type C1 Like 1 on cholesterol metabolism].
    Yang JY; Hu YW; Zhang P; Zheng L; Wang Q
    Sheng Li Xue Bao; 2012 Dec; 64(6):721-8. PubMed ID: 23258338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
    Davis HR; Veltri EP
    J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Respective contributions of intestinal Niemann-Pick C1-like 1 and scavenger receptor class B type I to cholesterol and tocopherol uptake: in vivo v. in vitro studies.
    Reboul E; Soayfane Z; Goncalves A; Cantiello M; Bott R; Nauze M; Tercé F; Collet X; Coméra C
    Br J Nutr; 2012 May; 107(9):1296-304. PubMed ID: 21929836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake.
    Weinglass AB; Köhler MG; Nketiah EO; Liu J; Schmalhofer W; Thomas A; Williams B; Beers L; Smith L; Hafey M; Bleasby K; Leone J; Tang YS; Braun M; Ujjainwalla F; McCann ME; Kaczorowski GJ; Garcia ML
    Mol Pharmacol; 2008 Apr; 73(4):1072-84. PubMed ID: 18187582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor.
    Liu W; Liang B; Zeng J; Meng J; Shi L; Yang S; Chang J; Wang C; Hu X; Wang X; Han N; Lu C; Li J; Wang C; Li H; Zhang R; Xing D
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of the apical and basolateral domains of the enterocyte in the regulation of cholesterol transport by a high glucose concentration.
    Grenier E; Mailhot G; Dion D; Ravid Z; Spahis S; Bendayan M; Levy E
    Biochem Cell Biol; 2013 Dec; 91(6):476-86. PubMed ID: 24219290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbers.
    Wang LJ; Wang J; Li N; Ge L; Li BL; Song BL
    J Biol Chem; 2011 Mar; 286(9):7397-408. PubMed ID: 21189420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of micelle characteristics on cholesterol absorption and ezetimibe inhibition: Insights from Niemann-Pick C1-like 1 binding and molecular structure.
    Aizawa H
    J Liposome Res; 2024 Sep; 34(3):386-398. PubMed ID: 37905576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virtual screening for cholesterol absorption inhibitors.
    Sun L; Qian H; Huang W
    Med Chem; 2014; 11(1):2-12. PubMed ID: 24773346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients.
    Zsíros N; Bodor M; Varga V; Berta E; Balogh I; Seres I; Paragh G; Harangi M
    Pharmazie; 2014 Jun; 69(6):424-9. PubMed ID: 24974575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling.
    Xiao J; Dong LW; Liu S; Meng FH; Xie C; Lu XY; Zhang WJ; Luo J; Song BL
    Nat Commun; 2023 Oct; 14(1):6469. PubMed ID: 37833289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia.
    Davies JP; Scott C; Oishi K; Liapis A; Ioannou YA
    J Biol Chem; 2005 Apr; 280(13):12710-20. PubMed ID: 15671032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbers.
    Yamanashi Y; Takada T; Suzuki H
    Pharmacogenet Genomics; 2009 Nov; 19(11):884-92. PubMed ID: 19823104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.